PLAYTEX DEODORANT TAMPONS, MODEL 34702

K020202 · Playtex Products, Inc. · HIL · Mar 12, 2002 · Obstetrics/Gynecology

Device Facts

• Record ID: K020202
• Device Name: PLAYTEX DEODORANT TAMPONS, MODEL 34702
• Applicant: Playtex Products, Inc.
• Product Code: HIL · Obstetrics/Gynecology
• Decision Date: Mar 12, 2002
• Decision: SESE
• Submission Type: Traditional
• Regulation: 21 CFR 884.5460
• Device Class: Class 2

Indications for Use

Scented or scented, deodorized menstrual tampon for the absorption of menstrual fluid.

Device Story

Playtex Deodorant Tampons are menstrual hygiene products designed for the absorption of menstrual fluid. The device consists of absorbent fibers and a string, intended for intravaginal insertion. It functions via physical absorption of fluid. The device is for over-the-counter use by menstruating individuals. It is intended to provide menstrual protection and odor control.

Clinical Evidence

No clinical data. Nonclinical testing included human sensitization, dermal irritation, acute oral toxicity, subacute vaginal irritation, agar diffusion, and TSST-1 toxin testing.

Technological Characteristics

Scented, deodorized menstrual tampon. Materials include fibers and string identical to predicate devices. Mode of action is physical absorption of menstrual fluid. No electronic or software components.

Indications for Use

Indicated for use as a scented or scented, deodorized menstrual tampon for the absorption of menstrual fluid in menstruating individuals.

Regulatory Classification

Identification

A scented or scented deodorized menstrual tampon is a device that is a plug made of cellulosic or synthetic material that is inserted into the vagina and used to absorb menstrual or other vaginal discharge. It has scent (i.e., fragrance materials) added for aesthetic purposes (scented menstrual tampon) or for deodorizing purposes (scented deodorized menstrual tampon). This generic type of device does not include menstrual tampons treated with added antimicrobial agents or other drugs.

Predicate Devices

• Playtex Deodorant Gentle Glide (Regular, Super, Super Plus)
• Playtex Deodorant Portables (Regular, Super)
• Playtex Deodorant Gentle Glide Multipack (Regular, Super)
• Deodorant Slimfits (Regular)

Submission Summary (Full Text)

{0}------------------------------------------------

K020 202

## MAR 1 2 2002

#### SUMMARY OF SAFETY AND EFFECTIVENESS A.

510(k) SUMMAR Y

1.

2.

9.

| COMPANY NAME | - | Playtex Products Inc. |
|---------------------|---|-------------------------------------------------------------------------------|
| ADDRESS | - | 75 Commerce Drive<br>Allendale, New Jersey 07401 |
| TELEPHONE | - | 201-785-8000 |
| CONTACT PERSON | - | M. Rosengarten<br>Director, Regulatory, Safety &<br>International Development |
| DATE OF SUMMARY | - | January 18, 2002 |
| DEVICE NAME | - | Playtex Tampons |
| CLASSIFICATION NAME | - | Scented, Deodorized Menstrual<br>Tampons |

- 3. The new Playtex tampons are substantially equivalent to the following tampons that have been previously cleared:
- a. Playtex Deodorant Gentle Glide® in Regular, Super and Super Plus absorbencies
- b. Playtex Deodorant Portables® in Regular and Super absorbencies
- c. Playtex Deodorant Gentle Glide Multipack in Regular and Super absorbencies
- d. Deodorant Slimfits® in Regular absorbency
- 4. The device description is: Scented, deodorized menstrual tampons for the absorption of menstrual fluid.
- న. Playtex tampons are intended to be used as scented, deodorized menstrual tampons for the absorption of menstrual fluid.
- The new ,tampon has the same technological characteristics as the 6. The fiber, string and materials in contact with the predicate device. vaginal wall are the same or have the same mode of action.
- B. 1. Nonclinical testing referenced for the determination of substantial equivalence includes:

Human sensitization, dermal irritation, acute oral toxicity, subacute vaginal irritations, agar diffusion and TSST-1 toxin testing.

- 2. Based on the review of the data referenced in this "510(k) Summary," the Playtex tampons are substantially equivalent to the predicate device in terms of safety and effectiveness.

{1}------------------------------------------------

#### DEPARTMENT OF HEALTH & HUMAN SERVICES

Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850

MAR 1 2 2002

Mr. Mark Rosengarten Director, Safety & International & International Development Playtex Products. Inc. Technical Center, 75 Commerce Dr. ALLENDALE NJ 07401-1600

Re: K020202

Trade/Device Name: Playtex Deodorant Tampons # 34702 Regulation Number: 21 CFR 884.5460 Regulation Name: Scented or scented deodorized menstrual tampon Regulatory Class: II

Product Code: 85 HIL Dated: January 18, 2002 Received: January 22, 2002

Dear Mr. Rosengarden:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration. Iisting of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (OS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (sections 531-542 of the Act); 21 CFR 1000-1050.

Image /page/1/Picture/12 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a circular seal with the text "DEPARTMENT OF HEALTH & HUMAN SERVICES • USA" around the perimeter. Inside the seal is a stylized symbol resembling a caduceus or a bird-like figure, composed of three curved lines.

{2}------------------------------------------------

This letter will allow you to begin marketing your device as described in your 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Office of Compliance at one of the following numbers, based on the regulation number at the top of this letter:

| 8xx.1xxx | [phone] |
|----------------------------------|----------------|
| 876.2xxx, 3xxx, 4xxx, 5xxx | [phone] |
| 884.2xxx, 3xxx, 4xxx, 5xxx, 6xxx | [phone] |
| 892.2xxx, 3xxx, 4xxx, 5xxx | [phone] |
| Other | [phone] |

Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at [phone]. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number [phone] or [phone] or at its Internet address http://www.fda.gov/cdrh/dsma/dsmamain.html.

Sincerely yours.

Nancy C. Brogdon

Nancy C. Brogdon Director, Division of Reproductive, Abdominal, and Radiological Devices Office of Device Evaluation Center for Devices and Radiological Health

Enclosure

{3}------------------------------------------------

### STATEMENT OF INDICATIONS OF USE PAGE

Page 1 _ of _1

# 510(k) Number (if known): K CaoaO

Device Name: Playtex Deodorant Gentle Glide, Playtex Deodorant Portables, Playeex Deodorant Gentle Gide® Multipack and Playtex Deodorant Slimfits® Tampons Model #34702

Indications For Use:

Scented or scented, deodorized menstrual tampon for the absorption of menstrual fluid.

#### (PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IF NEEDED)

Concurrence of CDRH, Office of Device Evaluation (ODE)

Prescription Use (Per 21 CFR 801.109) OR

Over-The-Counter Use

David A. Ingram

(Optional Format 1-2-96)